Health Policy
Carrie Colla, PhD
JAMA. 2021;325(8):715-716. doi:10.1001/jama.2020.26779
This Viewpoint discusses the unexpected large billing that can occur when a patient receives care from an out-of-network physician or center (surprise billing)—its root causes and recent legislation that will provide some patients with protection, but not all.
-
Editorial
Health Care Is a Right, Not a Privilege: A New Series on US Health Care and Health Policy
Howard Bauchner, MD; Phil B. Fontanarosa, MD, MBA; Karen Joynt Maddox, MD, MPH
-
Conversations with Dr Bauchner:
Health Care Reform in the Biden Era
Health Policy
Julia Adler-Milstein, PhD
JAMA. 2021;325(8):717-718. doi:10.1001/jama.2020.27014
This Viewpoint lays out policy priorities for advancing the digital transformation of US health information systems, including funding of infrastructure and enforcement of standards for EHR interoperability, data sharing, and usability.
-
Editorial
Health Care Is a Right, Not a Privilege: A New Series on US Health Care and Health Policy
Howard Bauchner, MD; Phil B. Fontanarosa, MD, MBA; Karen Joynt Maddox, MD, MPH
-
Conversations with Dr Bauchner:
Health Care Reform in the Biden Era
Leo Lopez III, MD, MHS; Louis H. Hart III, MD; Mitchell H. Katz, MD
free access
has active quiz
has audio
JAMA. 2021;325(8):719-720. doi:10.1001/jama.2020.26443
This Viewpoint reviews data demonstrating worse risk and outcomes for non-White patients with coronavirus disease 2019 (COVID-19) and makes policy proposals to mitigate the disparities, including expansion of Medicaid eligibility to expand health care access, multilingual and culturally appropriate communication and outreach, and easing accessibility to social services through health care contacts to address housing, food, legal, and economic stressors.
-
Audio Clinical Review:
Racial and Ethnic Disparities in COVID-19
H. Cody Meissner, MD
free access
JAMA. 2021;325(8):721-722. doi:10.1001/jama.2020.26792
This Viewpoint reviews the system in place to compensate US residents for proven vaccine injury via the Countermeasures Injury Compensation Program and emphasizes that the benefit of COVID-19 vaccines outweighs any potential harm.
-
Editorial
Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine
Howard Bauchner, MD; Preeti N. Malani, MD, MSJ; Joshua Sharfstein, MD
-
Conversations with Dr Bauchner:
COVID-19 Vaccine Approval and the FDA
-
Conversations with Dr Bauchner:
Coronavirus Update With Michael T. Osterholm, PhD, MPH
-
Conversations with Dr Bauchner:
Coronavirus Q&A With Anthony Fauci, MD – September 25, 2020
-
Conversations with Dr Bauchner:
Coronavirus Update With Anthony Fauci - October 28, 2020
-
Conversations with Dr Bauchner:
Coronavirus Vaccine Update With Anthony Fauci
Philip A. Pizzo, MD; David Spiegel, MD; Michelle M. Mello, JD, PhD
free access
has audio
JAMA. 2021;325(8):723-724. doi:10.1001/jama.2021.0122
This Viewpoint proposes response options for specialty societies, medical licensing boards, academic leadership, and faculty and colleagues when physician public health leaders spread misinformation detrimental to patients’ or the public’s health, as happened in the first year of the COVID-19 pandemic.
-
Conversations with Dr Bauchner:
When Physicians Engage in Practices That Threaten the Nation’s Health